Abstract WE574: Systematic Review and Meta-Analysis of Left-Sided Valvular Involvement in Intravenous Drug Use–Associated Infective Endocarditis
Abstract
Background: Right-sided infective endocarditis is classically linked to intravenous drug use (IVDU), yet contemporary reports suggest substantial left-sided and multivalvular disease. The true burden across valves and its clinical implications have not been quantified in a comprehensive synthesis. Hypothesis: We hypothesize that left-sided valve involvement represents a significant and underrecognized proportion of IVDU-associated infective endocarditis and is associated with higher rates of surgery and death compared with isolated right-sided disease. Methods: Following PRISMA 2020 and a PROSPERO-registered protocol (CRD420251010004), we searched PubMed, Embase, Scopus, and Web of Science (January 2021–December 2025) for studies enrolling adults (≥18 years) with echocardiography-confirmed IVDU-associated infective endocarditis. Random-effects meta-analysis (DerSimonian–Laird) estimated pooled prevalence and relative risk (RR) with 95% confidence intervals (CIs). Heterogeneity was assessed with I 2 , risk of bias with ROBINS-E, and small-study effects with funnel plots and sensitivity analyses. When reported, side-specific prevalences allowed both-sided cases to contribute to each side. Results: Fourteen studies (n=1,783 patients) met eligibility criteria. Pooled prevalence was 61% (95% confidence interval (CI)=57–65) for right-sided involvement, 41% (95% CI=35–47) for left-sided involvement, and 7% (95% CI=5–10) for both-sided disease. Valve-level involvement was tricuspid 61%, mitral 23%, aortic 17%, and pulmonic 1%. Compared with left-sided disease, right-sided involvement was more frequent (relative risk (risk ratio)=1.49; 95% CI=1.15–1.95; p=0.008). Staphylococcus aureus was the leading pathogen (73%), including methicillin-resistant strains in 17%. Valve surgery occurred in 21% and all-cause mortality in 17%. Findings were robust in leave-one-out and subgroup analyses with minimal evidence of publication bias. Conclusions: Left-sided valve involvement occurs in approximately two in five cases of IVDU-associated infective endocarditis, which is far higher than traditionally appreciated, and frequently affects the mitral and aortic valves. These data challenge the assumption of predominantly right-sided disease and support routine transesophageal echocardiography, early surgical evaluation, and integrated addiction care to improve outcomes in this high-risk population.
Article Details
Authors (25)
Minh Le
Hung Phan Huu
University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam, Ho Chi Minh, Viet Nam
Vien Truong
Department of Cardiology, The Christ Hospital Health Network, Lindner Research Center, Cincinnati, Ohio, United States
Minh Tang
Taipei Medical University, Houston, Texas, United States
Ky Phat Nguyen
International Master/Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
An Thuy Vo
Faculty of Pharmacy, Can Tho University of Medicine and Pharmacy, Can Tho, Viet Nam
Loc Vu
School of Medicine, Tan Tao University, Long An, Viet Nam
Duy Chung
Department of Internal Medicine, Northwest Healthcare Tucson, Tucson, Arizona, United States
Chi Duong
Department of Biomedical&Nutritional Sciences, University of Massachusetts Lowell, Lowell, Massachusetts, United States
Quoc Bui
South Texas Health System GME, McAllen, Texas, United States
Han Huynh
Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan
Trang Diep Thanh Le
Master Program in Graduate Institute of Metabolism and Obesity Sciences, College of Nutrition, Taipei Medical University, Taipei, Taiwan
Hoai Le
Cardiovascular Research Laboratories, Methodist Hospital, Merrillville, Indiana, United States
Hien Kha
International Master/Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
Nhi Huu Hanh Le
Phan Dai
Mien Dong Innovative Technology University, Dong Nai, Viet Nam
Dang Nguyen
Thu Huynh Minh Le
Department of Epidemiology, School of Public Health, The University of Texas Health Science Center at Houston, Houston, Texas, United States
Lam Chau
Department of Epidemiology, School of Public Health, The University of Texas Health Science Center at Houston, Houston, Texas, United States
Phat Huynh
North Carolina A&T State University, Greensboro, North Carolina, United States
Thach Nguyen
Interventional Cardiology Department, Methodist Hospital and St. Mary Medical Center, Merrillville, Indiana, United States
Thanh-Minh Nguyen
North Carolina A&T State University, Greensboro, North Carolina, United States
Thanh-Huy Nguyen
Carnegie Mellon University, Pittsburgh, Pennsylvania, United States
Jacques Kpodonu
Harvard Medical School, Boston, Massachusetts, United States
Nguyen Quoc Khanh Le
Taipei Medical University, Houston, Texas, United States